Dietary Protein and Physical Exercise for the Treatment of Sarcopenia.
ageing
dietary proteins
myokines
physical exercise
sarcopenia
skeletal muscle
Journal
Clinics and practice
ISSN: 2039-7275
Titre abrégé: Clin Pract
Pays: Switzerland
ID NLM: 101563282
Informations de publication
Date de publication:
25 Jul 2024
25 Jul 2024
Historique:
received:
31
05
2024
revised:
18
07
2024
accepted:
23
07
2024
medline:
28
8
2024
pubmed:
28
8
2024
entrez:
28
8
2024
Statut:
epublish
Résumé
Sarcopenia is a multifactorial age-related disorder that causes a decrease in muscle mass, strength, and function, leading to alteration of movement, risk of falls, and hospitalization. This article aims to review recent findings on the factors underlying sarcopenia and the strategies required to delay and counteract its symptoms. We focus on molecular factors linked to ageing, on the role of low-grade chronic and acute inflammatory conditions such as cancer, which contributes to the onset of sarcopenia, and on the clinical criteria for its diagnosis. The use of drugs against sarcopenia is still subject to debate, and the suggested approaches to restore muscle health are based on adequate dietary protein intake and physical exercise. We also highlight the difference in the amount and quality of amino acids within animal- and plant-based diets, as studies have often shown varying results regarding their effect on sarcopenia in elderly people. In addition, many studies have reported that non-pharmacological approaches, such as an optimization of dietary protein intake and training programs based on resistance exercise, can be effective in preventing and delaying sarcopenia. These approaches not only improve the maintenance of skeletal muscle function, but also reduce health care costs and improve life expectancy and quality in elderly people.
Identifiants
pubmed: 39194921
pii: clinpract14040117
doi: 10.3390/clinpract14040117
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1451-1467Subventions
Organisme : Next Generation EU in the framework of PRIN 2022, CUP I53D23004270006 (M.M.)
ID : CUP I53D23004270006